Immunovant, Inc.
IMVT
Revenue
0.00
0.000.00%
-Assets
1.05B
▲469.43M▲80.53%
3 Months ChangeLiabilities
66.26M
▲3.00M▲4.75%
3 Months ChangeFree Cash Flow
-117.41M
▼-41.03M▼-53.72%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2026-02-06
Form 10-Q
ID: 0001764013-26-000011
2026-02-06
Form 8-K
ID: 0001764013-26-000010
2025-12-12
Form 8-K
ID: 0001193125-25-317577
2025-12-11
Form 8-K
ID: 0001193125-25-314994
2025-11-21
Form 8-K
ID: 0001764013-25-000153
2025-11-10
Form 10-Q
ID: 0001764013-25-000149
2025-11-10
Form 8-K
ID: 0001764013-25-000148
2025-09-03
Form 8-K
ID: 0001764013-25-000136
2025-08-28
Form 8-K
ID: 0001764013-25-000132
2025-08-11
Form 10-Q
ID: 0001764013-25-000129